Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Bussink

Showing results (51-60 of 220) with videos related to

Pageof 22
Sort By:
International Journal of Radiation Oncology, Biology, Physics|July 5, 2019
Inhibition of CDK4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell CarcinomasEva-Leonne Göttgens, Johan Bussink, Katarzyna B Leszczynska, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trialAswin L Hoffmann, Esther G C Troost, Henk Huizenga, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2013
Low phosphorylated AKT expression in laryngeal cancer: indications for a higher metastatic riskMonique M Nijkamp, Paul N Span, Hanneke Stegeman, et al.
BMC Cancer|May 17, 2011
Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4Saskia E Rademakers, Jasper Lok, Albert J van der Kogel, et al.
Nature Reviews. Clinical Oncology|January 26, 2011
PET-CT for radiotherapy treatment planning and response monitoring in solid tumorsJohan Bussink, Johannes H A M Kaanders, Winette T A van der Graaf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2010
A practical approach to assess clinical planning tradeoffs in the design of individualized IMRT treatment plansRené Monshouwer, Aswin L Hoffmann, Martina Kunze-Busch, et al.
Molecular Pharmaceutics|December 15, 2018
Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft ModelsFokko J Huizing, Bianca A W Hoeben, Gerben M Franssen, et al.
Head & Neck|June 2, 2016
Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinomaCarmen P Liskamp, Geert O Janssens, Johan Bussink, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2013
The PERK/ATF4/LAMP3-arm of the unfolded protein response affects radioresistance by interfering with the DNA damage responseAnika Nagelkerke, Johan Bussink, Albert J van der Kogel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2025
Mitochondria Targeting of Oxidative Phosphorylation Inhibitors to Alleviate Hypoxia and Enhance Anticancer Treatment EfficacyAnne P M Beerkens, Sandra Heskamp, Flavia V Reinema, et al.
Pageof 22

Showing results (51-60 of 220) with videos related to

Sort By:
Pageof 22
International Journal of Radiation Oncology, Biology, Physics|July 5, 2019
Inhibition of CDK4/CDK6 Enhances Radiosensitivity of HPV Negative Head and Neck Squamous Cell CarcinomasEva-Leonne Göttgens, Johan Bussink, Katarzyna B Leszczynska, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Individualized dose prescription for hypofractionation in advanced non-small-cell lung cancer radiotherapy: an in silico trialAswin L Hoffmann, Esther G C Troost, Henk Huizenga, et al.
International Journal of Radiation Oncology, Biology, Physics|July 27, 2013
Low phosphorylated AKT expression in laryngeal cancer: indications for a higher metastatic riskMonique M Nijkamp, Paul N Span, Hanneke Stegeman, et al.
BMC Cancer|May 17, 2011
Metabolic markers in relation to hypoxia; staining patterns and colocalization of pimonidazole, HIF-1α, CAIX, LDH-5, GLUT-1, MCT1 and MCT4Saskia E Rademakers, Jasper Lok, Albert J van der Kogel, et al.
Nature Reviews. Clinical Oncology|January 26, 2011
PET-CT for radiotherapy treatment planning and response monitoring in solid tumorsJohan Bussink, Johannes H A M Kaanders, Winette T A van der Graaf, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 16, 2010
A practical approach to assess clinical planning tradeoffs in the design of individualized IMRT treatment plansRené Monshouwer, Aswin L Hoffmann, Martina Kunze-Busch, et al.
Molecular Pharmaceutics|December 15, 2018
Quantitative Imaging of the Hypoxia-Related Marker CAIX in Head and Neck Squamous Cell Carcinoma Xenograft ModelsFokko J Huizing, Bianca A W Hoeben, Gerben M Franssen, et al.
Head & Neck|June 2, 2016
Adverse effect of smoking on prognosis in human papillomavirus-associated oropharyngeal carcinomaCarmen P Liskamp, Geert O Janssens, Johan Bussink, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 30, 2013
The PERK/ATF4/LAMP3-arm of the unfolded protein response affects radioresistance by interfering with the DNA damage responseAnika Nagelkerke, Johan Bussink, Albert J van der Kogel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2025
Mitochondria Targeting of Oxidative Phosphorylation Inhibitors to Alleviate Hypoxia and Enhance Anticancer Treatment EfficacyAnne P M Beerkens, Sandra Heskamp, Flavia V Reinema, et al.
Pageof 22